Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00271856 · ClinicalTrials.gov registry record · Phase 2
Staying Well: A Clinical Trial of Mindfulness-Based Stress Reduction and Education Groups for HIV
A Phase 2 study of HIV, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 2
- Development phase
- 177
- Enrollment target
- 1
- Study location
NCT00271856 is a Phase 2 study of HIV that has completed, run by University of California, San Francisco. The registered enrollment target is 177 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00271856, a Phase 2 study of HIV, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 177 participants
- Enrollment target
- 1
- Study location
Study Summary
To examine the effects of Mindfulness-Based Stress Reduction (MBSR) and education groups on HIV (Human Immunodeficiency Syndrome) infection. Key outcomes include CD4 and viral load, stress hormones, depression and quality of life.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness-Based Stress Reduction (MBSR)
- BEHAVIORAL HIV-education and self-management workshop
Study Locations (1)
California
- Osher Center for Integrative Medicine - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2005-05 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00271856
The ClinicalTrials.gov registry entry for NCT00271856 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (60% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness-Based Stress Reduction (MBSR) is the first listed.
NCT00271856 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00271856 about?
NCT00271856 is a clinical study titled "Staying Well: A Clinical Trial of Mindfulness-Based Stress Reduction and Education Groups for HIV". To examine the effects of Mindfulness-Based Stress Reduction (MBSR) and education groups on HIV (Human Immunodeficiency Syndrome) infection. Key outcomes include CD4 and viral load, stress hormones, depression and quality of life.
What is the current status of trial NCT00271856?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 177 participants. The study started on 2005-05. Estimated completion is 2009-09.
What conditions does trial NCT00271856 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT00271856?
The interventions under investigation include: Mindfulness-Based Stress Reduction (MBSR) (BEHAVIORAL), HIV-education and self-management workshop (BEHAVIORAL).
Who is sponsoring clinical trial NCT00271856?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00271856 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
Improving Physical Ability and Cellular Senescence Elimination in HIV
RECRUITING · Phase 2
-
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
RECRUITING · Phase 2
-
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
RECRUITING · Phase 2
-
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
RECRUITING · Phase 2
-
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.